Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

Kennedy Jr. appeared on the latest episode of Tucker Carlson’s podcast on Monday and it’s filled with the ramblings of a man ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

Sweeping child welfare legislation is poised to help more children get the care they need, state officials say, amid recent ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Precision oncology has entered a new phase, as data sets mature and a new wave of tools emerges to help clinicians manage ...

China’s National Medical Products Administration (NMPA) has approved four new drugs developed by local biopharma companies, ...

New drugs that target 'zombie' tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of ...

A breakthrough brain scan shows Parkinson’s drugs can misfire in the brain, helping some patients less than others. The fix?

A federal lawsuit is targeting a new Oklahoma law that puts conditions on how much drug manufacturers can charge when selling ...